HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pascale Morineau-Le Houssine Selected Research

XAV-19

3/2021Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pascale Morineau-Le Houssine Research Topics

Disease

1COVID-19
03/2021
1Infections
03/2021
1Pneumonia (Pneumonitis)
03/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2013

Drug/Important Bio-Agent (IBA)

1Neutralizing AntibodiesIBA
03/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1XAV-19IBA
03/2021

Therapy/Procedure

1Immunotherapy
03/2021
1Therapeutics
06/2013